Quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR) in translational oncology: Lung cancer perspective

Lung Cancer

Volumn 59, Issue 2, 2008, Pages 147-154

  Skrzypski, Marcin ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Detection; Lung cancer; Normalization; Oligonucleotide microarrays; Predictive factors; Prognosis; Quantitative reverse transcriptase real time polymerase chain reaction (qRT PCR); Staging

Indexed keywords

MESSENGER RNA; RIBOSOME RNA; TUMOR MARKER;

CANCER RESEARCH; CANCER STAGING; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LUNG CANCER; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; STATISTICAL PARAMETERS;

DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 38649134174     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.11.008     Document Type: Review

References (62)

1. Stahlberg A., Kubista M., and Pfaffl M. Comparison of reverse transcriptases in gene expression analysis. Clin Chem 50 (2004) 1678-1680
2. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25 (2000) 169-193
3. Wei S., and To S.S. Influence of RNA secondary structure on HEV gene amplification using reverse-transcription and nested polymerase chain reaction. J Clin Virol 27 (2003) 152-161
4. Witwer C., Rauscher S., Hofacker I.L., and Stadler P.F. Conserved RNA secondary structures in Picornaviridae genomes. Nucl Acids Res 29 (2001) 5079-5089
5. Stangegaard M. DIHaDM: reverse transcription using random pentadecamer primers increases yield and quality of resulting cDNA. Biotechniques 40 (2006) 649-657
6. Wittwer C.T., Herrmann M.G., Gundry C.N., and Elenitoba-Johnson K.S. Real-time multiplex PCR assays. Methods 25 (2001) 430-442
7. Bustin S.A., and Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 15 (2004) 155-166
8. Zhang J., and Byrne C.D. Differential priming of RNA templates during cDNA synthesis markedly affects both accuracy and reproducibility of quantitative competitive reverse-transcriptase PCR. Biochem J 337 Pt 2 (1999) 231-241
9. Stahlberg A., Hakansson J., Xian X., Semb H., and Kubista M. Properties of the reverse transcription reaction in mRNA quantification. Clin Chem 50 (2004) 509-515
10. Wong M.L., and Medrano J.F. Real-time PCR for mRNA quantitation. Biotechniques 39 (2005) 75-85
11. Peirson S.N., Butler J.N., and Foster R.G. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucl Acids Res 31 (2003) e73
12. Fronhoffs S., Totzke G., Stier S., Wernert N., Rothe M., Bruning T., et al. A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol Cell Probes 16 (2002) 99-110
13. Gerard C.J., Olsson K., Ramanathan R., Reading C., and Hanania E.G. Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards. Cancer Res 58 (1998) 3957-3964
14. Liss B. Improved quantitative real-time RT-PCR for expression profiling of individual cells. Nucl Acids Res 30 (2002) e89
15. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
16. Liu W., and Saint D.A. A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 302 (2002) 52-59
17. Marino J.H., Cook P., and Miller K.S. Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time RT-PCR. J Immunol Meth 283 (2003) 291-306
18. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 29 (2001) e45
19. Freeman W.M., Walker S.J., and Vrana K.E. Quantitative RT-PCR: pitfalls and potential. Biotechniques 26 1 (1999) 112-22, 124-5
20. Tichopad A., Dilger M., Schwarz G., and Pfaffl M.W. Standardized determination of real-time PCR efficiency from a single reaction set-up. Nucl Acids Res 31 (2003) e122
21. Livak K. ABI Prism 7700 sequence. Detection system, user bulletin 2. PE Appl Biosyst; 1997.
22. Bieche I., Onody P., Laurendeau I., Olivi M., Vidaud D., Lidereau R., et al. Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications. Clin Chem 45 (1999) 1148-1156
23. Liu D.W., Chen S.T., and Liu H.P. Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur Respir J 26 (2005) 1002-1008
24. Silvia S., Francesca C., Marco L.I., Silvia N., Giorgio V.S., and Raffaele C.A. Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer. BMC Cancer 6 (2006) 200
25. Barbu V., and Dautry F. Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucl Acids Res 17 (1989) 7115
26. Banerjee S., An S., and Makino S. Specific cleavage of 28S ribosomal RNA in murine coronavirus-infected cells. Adv Exp Med Biol 494 (2001) 621-626
27. Tricarico C., Pinzani P., Bianchi S., Paglierani M., Distante V., Pazzagli M., et al. Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 309 (2002) 293-300
28. Pfaffl M.W., Tichopad A., Prgomet C., and Neuvians T.P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 26 (2004) 509-515
29. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 (2002) RESEARCH0034
30. de Kok J.B., Roelofs R.W., Giesendorf B.A., Pennings J.L., Waas E.T., Feuth T., et al. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 85 (2005) 154-159
31. Hamalainen H.K., Tubman J.C., Vikman S., Kyrola T., Ylikoski E., Warrington J.A., et al. Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. Anal Biochem 299 (2001) 63-70
32. Goulter A.B., Harmer D.W., and Clark K.L. Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue. BMC Genomics 7 (2006) 34
33. Ling Y.H., Li T., Yuan Z., Haigentz Jr. M., Weber T.K., and Perez-Soler R. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 upregulation and nuclear translocation in association with cell growth inhibition and cell cycle arrest in human non-small cell lung cancer cell lines. Mol Pharmacol (2007)
34. Yabuki N., Sakata K., Yamasaki T., Terashima H., Mio T., Miyazaki Y., et al. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance. Cancer Genet Cytogenet 173 (2007) 1-9
35. Miura N., Nakamura H., Sato R., Tsukamoto T., Harada T., Takahashi S., et al. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Sci (2006)
36. Maeda J., Inoue M., Okumura M., Ohta M., Minami M., Shiono H., et al. Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity. Lung Cancer 52 (2006) 235-240
37. Nosotti M., Falleni M., Palleschi A., Pellegrini C., Alessi F., Bosari S., et al. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker. Chest 128 (2005) 1539-1544
38. D'Cunha J., Corfits A.L., Herndon II J.E., Kern J.A., Kohman L.J., Patterson G.A., et al. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer-preliminary results of Cancer and Leukemia Group B Trial 9761. J Thorac Cardiovasc Surg 123 (2002) 484-491 discussion 491
39. Castaldo G., Tomaiuolo R., Sanduzzi A., Ponticiello A., Marchetiello I., and Salvatore F. Carcinoembryonic antigen mRNA analysis detects micrometastatic cells in blood from lung cancer patients. Eur Respir J 22 (2003) 418-421
40. Sienel W., Mecklenburg I., Dango S., Ehrhardt P., Kirschbaum A., Passlick B., et al. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer. Clin Cancer Res 13 (2007) 3840-3847
41. Douillard J.Y., Rosell R., De Lena M., Carpagnano F., Ramlau R., Gonzales-Larriba J.L., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7 (2006) 719-727
42. Solakoglu O., Maierhofer C., Lahr G., Breit E., Scheunemann P., Heumos I., et al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proc Natl Acad Sci USA 99 (2002) 2246-2251
43. Pierga J.Y., Bonneton C., Magdelenat H., Vincent-Salomon A., Nos C., Boudou E., et al. Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients. Int J Cancer 114 (2005) 291-298
44. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98 (2001) 13790-13795
45. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8 (2002) 816-824
46. Schuchhardt J., Beule D., Malik A., Wolski E., Eickhoff H., Lehrach H., et al. Normalization strategies for cDNA microarrays. Nucl Acids Res 28 (2000) E47
47. Dallas P.B., Gottardo N.G., Firth M.J., Beesley A.H., Hoffmann K., Terry P.A., et al. Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR-how well do they correlate?. BMC Genomics 6 (2005) 59
48. Wang Y., Barbacioru C., Hyland F., Xiao W., Hunkapiller K.L., Blake J., et al. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics 7 (2006) 59
49. Chen H.Y., Yu S.L., Chen C.H., Chang G.C., Chen C.Y., Yuan A., et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356 (2007) 11-20
50. Rajeevan M.S., Vernon S.D., Taysavang N., and Unger E.R. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 3 (2001) 26-31
51. Endoh H., Tomida S., Yatabe Y., Konishi H., Osada H., Tajima K., et al. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol 22 (2004) 811-819
52. 2007 ASCO annual meeting proceedings, part I. J Clin Oncol; 2007.
53. Alam N., Shepherd F.A., Winton T., Graham B., Johnson D., Livingston R., et al. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and Intergroup Trial JBR.10 and a review of the literature. Lung Cancer 47 (2005) 385-394
54. Paik S., Tang G., Shak S., Kim C., Baker J., Kim W., et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24 (2006) 3726-3734
55. Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 (2004) 2817-2826
56. Dziadziuszko R., Witta S.E., Cappuzzo F., Park S., Tanaka K., Danenberg P.V., et al. Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer. Clin Cancer Res 12 (2006) 3078-3084
57. Coldren C.D., Helfrich B.A., Witta S.E., Sugita M., Lapadat R., Zeng C., et al. Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines. Mol Cancer Res 4 (2006) 521-528
58. Schrump D.S., Fischette M.R., Nguyen D.M., Zhao M., Li X., Kunst T.F., et al. Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura. Clin Cancer Res 12 (2006) 5777-5785
59. Niho S., Kubota K., Goto K., Yoh K., Ohmatsu H., Kakinuma R., et al. First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 24 (2006) 64-69
60. Antonov J., Goldstein D.R., Oberli A., Baltzer A., Pirotta M., Fleischmann A., et al. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 85 (2005) 1040-1050
61. Rupp G.M., and Locker J. Purification and analysis of RNA from paraffin-embedded tissues. Biotechniques 6 (1988) 56-60
62. Cronin M., Pho M., Dutta D., Stephans J.C., Shak S., Kiefer M.C., et al. Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol 164 (2004) 35-42